Both in Pharmaceuticals
FibroBiologics vs Ensysce Biosciences
Over the past year FBLG returned −88.1% and ENSC returned −79.0%; their daily moves had a correlation of 0.03.
FBLG −88.1% ENSC −79.0%Growth of $1, one year, split-adjusted
| Metric | FBLG | ENSC |
|---|---|---|
| Price | $0.9281 | $0.4380 |
| Market cap | $6.6M | $8.5M |
| Today | −3.99% | −3.16% |
| 1 month | −28.6% | +5.3% |
| 6 months | −29.7% | +17.9% |
| Year to date | −79.4% | −52.4% |
| 1 year | −89.0% | −79.2% |
| Revenue growth (YoY) | — | −15.1% |
| Gross margin | — | 100.0% |
| Net margin | — | −220.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 1.9× |
| Net cash | $3.5M | $479.9K |
| Dividend yield | — | — |
| Volatility (60d) | 102.9% | 121.6% |
| Short % of float | 6.0% | 2.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).